Xiaoping Zhao

3.5k total citations
84 papers, 2.8k citations indexed

About

Xiaoping Zhao is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Xiaoping Zhao has authored 84 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 36 papers in Cancer Research and 13 papers in Epidemiology. Recurrent topics in Xiaoping Zhao's work include Cancer, Hypoxia, and Metabolism (17 papers), Cancer, Lipids, and Metabolism (14 papers) and RNA modifications and cancer (11 papers). Xiaoping Zhao is often cited by papers focused on Cancer, Hypoxia, and Metabolism (17 papers), Cancer, Lipids, and Metabolism (14 papers) and RNA modifications and cancer (11 papers). Xiaoping Zhao collaborates with scholars based in China, United States and Ireland. Xiaoping Zhao's co-authors include Gang Huang, Li Zhao, Jianjun Liu, Yan Sun, Fajun Yang, Yuhong Zhou, Jiajin Li, Yu Hu, Jianjun Liu and Mengqin Shen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

In The Last Decade

Xiaoping Zhao

79 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Zhao China 32 1.8k 1.2k 500 299 249 84 2.8k
Brian F. Clem United States 25 2.0k 1.1× 1.6k 1.3× 594 1.2× 176 0.6× 166 0.7× 52 2.8k
Marie C. Lin China 34 2.5k 1.4× 1.8k 1.5× 603 1.2× 333 1.1× 277 1.1× 56 3.7k
Laura V. Danai United States 19 1.8k 1.0× 1.2k 1.0× 404 0.8× 178 0.6× 298 1.2× 23 2.9k
Aaron D. Tward United States 23 1.6k 0.9× 762 0.6× 631 1.3× 448 1.5× 151 0.6× 40 3.4k
Wenjing Du China 20 1.8k 1.0× 1.3k 1.1× 623 1.2× 186 0.6× 207 0.8× 36 2.7k
Yang‐Sook Chun South Korea 33 2.1k 1.1× 1.5k 1.2× 682 1.4× 222 0.7× 373 1.5× 68 3.6k
Jessica L. Yecies United States 10 2.0k 1.1× 926 0.8× 319 0.6× 433 1.4× 468 1.9× 13 3.0k
Karim Bensaad United Kingdom 14 2.6k 1.4× 2.0k 1.7× 829 1.7× 242 0.8× 410 1.6× 18 3.7k
Gerta Hoxhaj United States 18 2.7k 1.4× 878 0.7× 456 0.9× 276 0.9× 383 1.5× 24 3.7k
Chunming Cheng United States 17 1.9k 1.0× 1.5k 1.3× 261 0.5× 356 1.2× 141 0.6× 35 2.8k

Countries citing papers authored by Xiaoping Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Zhao more than expected).

Fields of papers citing papers by Xiaoping Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Zhao. The network helps show where Xiaoping Zhao may publish in the future.

Co-authorship network of co-authors of Xiaoping Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Zhao. A scholar is included among the top collaborators of Xiaoping Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Zhao. Xiaoping Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Mengqin, Haitao Zhao, Hua Qian, et al.. (2025). Deacetylation of ACLY Mediates RNA M 6 A‐Modification of NOXA and Promotes Chemoresistance of Colorectal Cancer. Advanced Science. 12(47). e03323–e03323.
4.
Yang, Chen, Xunan Jing, Xiaoping Zhao, et al.. (2023). Antimicrobial, Antioxidant, and Anti‐Inflammatory Nanoplatform for Effective Management of Infected Wounds. Advanced Healthcare Materials. 13(5). e2302868–e2302868. 21 indexed citations
5.
Shen, Mengqin, Ruixue Zhang, Zongping Zhu, et al.. (2021). Nuclear scaffold protein p54nrb/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma. Oncogene. 40(24). 4167–4183. 20 indexed citations
6.
Que, Keting, et al.. (2021). Effect of TRAF1 on Phenotypic Changes Of Kupffer Cells In Liver Transplantation Ischemic-Reperfusion. Current Pharmaceutical Biotechnology. 22(12). 1602–1611. 1 indexed citations
8.
An, Shuxian, Liangqian Huang, Ping Miao, et al.. (2018). Small ubiquitin-like modifier 1 modification of pyruvate kinase M2 promotes aerobic glycolysis and cell proliferation in A549 human lung cancer cells. OncoTargets and Therapy. Volume 11. 2097–2109. 24 indexed citations
9.
Sun, Yan, Wenfang Peng, Weiwei He, et al.. (2018). Transgelin-2 is a novel target of KRAS-ERK signaling involved in the development of pancreatic cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 166–166. 13 indexed citations
10.
Zhao, Xiaoping, Li Zhao, Hui Yan, et al.. (2018). Non-canonical roles of PFKFB3 in regulation of cell cycle through binding to CDK4. Oncogene. 37(13). 1685–1698. 43 indexed citations
11.
Zhao, Xiaoping, et al.. (2017). NSAIDs Use and Reduced Metastasis in Cancer Patients: results from a meta-analysis. Scientific Reports. 7(1). 1875–1875. 68 indexed citations
12.
Yan, Tinglin, Meng Wang, Zhi Xu, et al.. (2017). Up-regulation of syncytin-1 contributes to TNF-α-enhanced fusion between OSCC and HUVECs partly via Wnt/β-catenin-dependent pathway. Scientific Reports. 7(1). 40983–40983. 34 indexed citations
13.
Zhao, Xiaoping, et al.. (2016). Experimental study of solute transport in pool-pipe system and its significance on karst hydrogeology. AGU Fall Meeting Abstracts. 2016. 2 indexed citations
14.
Zhou, Xiang, Ruohua Chen, Zhenhai Yu, et al.. (2015). Dichloroacetate restores drug sensitivity in paclitaxel-resistant cells by inducing citric acid accumulation. Molecular Cancer. 14(1). 63–63. 52 indexed citations
15.
Li, Jiajin, Xiang Zhou, Teng Zhang, et al.. (2013). Inhibition of Lipolysis by Mercaptoacetate and Etomoxir Specifically Sensitize Drug-Resistant Lung Adenocarcinoma Cell to Paclitaxel. PLoS ONE. 8(9). e74623–e74623. 39 indexed citations
16.
Huang, Xiaolin, Li Wang, He Zhang, et al.. (2012). Therapeutic Efficacy By Targeting Correction Of Notch1-induced Aberrants In Uveal Tumors. Investigative Ophthalmology & Visual Science. 53(14). 6876–6876. 1 indexed citations
17.
Zhao, Xiaoping & Fajun Yang. (2012). Regulation of SREBP-Mediated Gene Expression. PubMed. 28(4). 287–287. 28 indexed citations
18.
Zhao, Xiaoping, Daorong Feng, Arian Abdulla, et al.. (2012). Regulation of lipogenesis by cyclin-dependent kinase 8–mediated control of SREBP-1. Journal of Clinical Investigation. 122(7). 2417–2427. 169 indexed citations
19.
Wang, Min, Ping Wang, Sha Wu, et al.. (2008). The altered expression of glucose-regulated proteins 78 in different phase of streptozotocin-affected pancreatic beta-cells. Cell Stress and Chaperones. 14(1). 43–48. 19 indexed citations
20.
Lei, Ping, Tao Yu, Huifen Zhu, et al.. (2004). Construction and Expression of Recombinant Gene for Fusion of Human Stem Cell Factor and EGFP. 1(4). 220–223. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026